Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98  J. Robert, E. Cambau, K. Grenet, D.

Slides:



Advertisements
Similar presentations
Models for the organisation of hospital infection control and prevention programmes B. Gordts Clinical Microbiology and Infection Volume 11, Pages
Advertisements

Laboratory diagnosis and biosafety issues of biological warfare agents
Interpretive criteria of ceftibuten disk diffusion susceptibility tests according to the DIN method  Kleinkauf N. , Rodloff A.C.   Clinical Microbiology.
S. Biswas, D. Raoult, J.-M. Rolain  Clinical Microbiology and Infection 
M.A.C. Broeren, Y. Maas, E. Retera, N.L.A. Arents 
Approach to diagnosis of infective endocarditis
Molecular characterization of methicillin-resistant Staphylococcus aureus isolated over a 2-year period in a Qatari hospital from multinational patients 
Antimicrobial resistance in viridans group streptococci among patients with and without the diagnosis of cancer in the USA, Canada and Latin America 
A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes  G. Kronvall, G. Kahlmeter, E.
P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys 
Herpes zoster in non-hospitalized children
In-vitro susceptibility and molecular characterisation of macrolide resistance mechanisms among Streptococcus pneumonia isolates in The Netherlands: the.
A new method for normalized interpretation of antimicrobial resistance from disk test results for comparative purposes  G. Kronvall, G. Kahlmeter, E.
Gentamicin susceptibility in Escherichia coli related to the genetic background: problems with breakpoints  L. Jakobsen, D. Sandvang, V.F. Jensen, A.M.
Quinolone resistance among Shigella spp
P. Nordmann, L. Poirel  Clinical Microbiology and Infection 
E. Cambau, M. Drancourt  Clinical Microbiology and Infection 
Louis Pasteur, from crystals of life to vaccination
How to evaluate and predict the ecologic impact of antibiotics: the pharmaceutical industry view from research and development  R. Bax  Clinical Microbiology.
Revision of linezolid disk diffusion quality control guidelines for testing Staphylococcus aureus ATCC 25923: an independent seven-laboratory trial  D.J.
Impact of changes in CLSI and EUCAST breakpoints for susceptibility in bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia.
Sofie Arens, Jan Verhaegen, Ludo Verbist 
Training for the infectious diseases speciality in Norway
The antibacterial effects of ciprofloxacin and trovafloxacin against Streptococcus pneumoniae in an in vitro dynamic model  Matthew O'Brien, Thuy Quach,
E.C. Böttger  Clinical Microbiology and Infection 
Cephalosporins: a pharmacological update
Low prevalence of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in Belgian hospitals  C. Nonhoff, O. Denis,
D. Esel, B. Sümerkan, S. Kocagöz  Clinical Microbiology and Infection 
Laboratory diagnosis and biosafety issues of biological warfare agents
Comparative in vitro activity of ertapenem against bacterial pathogens isolated from patients with lower respiratory tract infections  P.S. Hicks, B.
C. -J. Soussy, J. Nguyen, F. Goldstein, H. Dabernat, A. Andremont, R
G. Kronvall  Clinical Microbiology and Infection 
S. Bengtsson, C. Bjelkenbrant, G. Kahlmeter 
In vitro selection of antibiotic resistance in Pseudomonas aeruginosa
Antimicrobial susceptibility in Escherichia coli of human and avian origin—a comparison of wild-type distributions  M. Sjölund, S. Bengtsson, J. Bonnedahl,
Isolation rate, T-serotyping and susceptibility to antibiotics of Group A Streptococcus from pediatric infections in Athens*   M. Kanellopoulou, A. Makri,
Effect of antioxidants on the immune response of Helicobacter pylori
L. Arreaza, J.A. Vázquez  Clinical Microbiology and Infection 
Laboratory diagnosis of Clostridium difficile disease
N. Maggi-Solcà, C. Valsangiacomo, J.-C. Piffaretti 
Jacques Sirot, Patrice Courvalin, Claude-James Soussy 
Recent developments in staphylococcal scalded skin syndrome
R. Colebunders, P. Michielsen  Clinical Microbiology and Infection 
T.M. File  Clinical Microbiology and Infection 
Long-term study of the frequency of Escherichia coli and Klebsiella pneumoniae isolates producing extended-spectrum β-lactamases  L. Romero, L. López,
Harmonised monitoring of antimicrobial resistance in Salmonella and Campylobacter isolates from food animals in the European Union  S. Bronzwaer  Clinical.
Community-acquired pneumonia: epidemiologic and clinical consideration
Pandemic lineages of extraintestinal pathogenic Escherichia coli
Comparative antimicrobial spectrum and activity of the desfluoroquinolone BMS (T-3811) tested against non-fermentative Gram-negative bacilli  W.
Circulation of international clones of levofloxacin non-susceptible Streptococcus pneumoniae in Taiwan  Y.-C. Hsieh, L.-Y. Chang, Y.-C. Huang, H.-C. Lin,
C. Gagliotti, L. Nobilio, M.L. Moro 
Statin use and clinical outcomes among pneumonia patients
Clinical Microbiology and Infection
Clinical Microbiology and Infection
W. Eugene Sanders, Christine C. Sanders 
Overview of cefixime use in community-acquired infections
Calibration of the disk diffusion test for trovafloxacin susceptibility testing of four anaerobic species  G. Kronvall, E. Holst  Clinical Microbiology.
K. Kaier, N.T. Mutters, U. Frank  Clinical Microbiology and Infection 
Facilitating learning and change in physicians: Implications for a system of continuing medical education in Europe  Robert D. Fox  Clinical Microbiology.
Abstracts Clinical Microbiology and Infection
In vitro activity of evernimicin and selected antibiotics against methicillin-resistant staphylococci: a 24-country study  R. Goering, C.-E. Nord, R.
European recommendations for antimicrobial resistance surveillance
Susceptibility of multi-drug-resistant Pseudomonas aeruginosa in intensive care units: results from the European MYSTIC study group†   H. Goossens  Clinical.
J.L. Balcázar  Clinical Microbiology and Infection 
G.C. Schito  Clinical Microbiology and Infection 
The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands  J.W. Mouton, A.R. Jansz  Clinical.
Typing of Clostridium difficile
G. Kahlmeter  Clinical Microbiology and Infection 
Activity of linezolid against Gram-positive cocci isolated in French hospitals as determined by three in-vitro susceptibility testing methods  C. Muller-Serieys,
The future of diagnostic bacteriology
Presentation transcript:

Trends in quinolone susceptibility of Enterobacteriaceae among inpatients of a large university hospital: 1992–98  J. Robert, E. Cambau, K. Grenet, D. Trystram, Y. Péan, M.-H. Fiévet, V. Jarlier  Clinical Microbiology and Infection  Volume 7, Issue 10, Pages 553-561 (October 2001) DOI: 10.1046/j.1198-743x.2001.00322.x Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 1 Distribution (%) of the inhibition zone diameters for nalidixic acid against all Escherichia coli strains (a) and for ciprofloxacin against Escherichia coli strains resistant to nalidixic acid (b). Clinical Microbiology and Infection 2001 7, 553-561DOI: (10.1046/j.1198-743x.2001.00322.x) Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Figure 2 Distribution (%) of the minimal inhibitory concentrations (MICs) of ciprofloxacin against nalidixic acid-resistant Escherichia coli (a) and K. pneumoniae (b). Clinical Microbiology and Infection 2001 7, 553-561DOI: (10.1046/j.1198-743x.2001.00322.x) Copyright © 2001 European Society of Clinical Infectious Diseases Terms and Conditions

Feedback: Privacy Policy Feedback
Do Not Sell My Personal Information
About project: SlidePlayer Terms of Service

© 2025 SlidePlayer.com. Inc. All rights reserved.